Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Bleda

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Clinical Medicine Insights. Cardiology|November 15, 2016
Rationale and Design of Randomized Clinical Trial for the Assessment of Macitentan Efficiency as Coadjuvant Treatment to Open and Endovascular Revascularization in Critical Limb IschemiaIgnacio Michel, Joaquin De Haro, Silvia Bleda, et al.
Vascular and Endovascular Surgery|August 3, 2010
The role of foot collateral vessels on ulcer healing and limb salvage after successful endovascular and surgical distal procedures according to an angiosome modelCésar Varela, Francisco Acín, Joaquín de Haro, et al.
Journal of Vascular Surgery|January 30, 2014
Circulating anti-β2-glycoprotein I antibodies of peripheral arterial disease patients trigger a genomic overexpression of Toll-like receptor 4 in endothelial cellsCesar Varela, Joaquin de Haro, Silvia Bleda, et al.
Annals of Vascular Surgery|April 23, 2019
Aspirin-Dependent Platelet Inflammatory Inhibition in Healthy Subjects Decreases NLRP-1 InflammasomeJoaquin De Haro, Silvia Bleda, Ilsem Veronica Laime, et al.
Therapeutic Advances in Cardiovascular Disease|March 13, 2018
Differential mRNA expression of inflammasome genes NLRP1 and NLRP3 in abdominal aneurysmal and occlusive aortic diseaseCarmen Gonzalez-Hidalgo, Joaquin De Haro, Silvia Bleda, et al.
Interactive Cardiovascular and Thoracic Surgery|August 20, 2011
Anti-endothelial cell antibodies are associated with peripheral arterial disease and markers of endothelial dysfunction and inflammationCesar Varela, Joaquin de Haro, Silvia Bleda, et al.
Annals of Vascular Surgery|February 14, 2013
Inflammatory burden predicts long-term outcomes in endovascular therapy in peripheral arterial diseaseSilvia Bleda, Joaquin De Haro, Francisco Acin, et al.
Growth Factors (Chur, Switzerland)|July 6, 2012
Impact of VEGF polymorphisms on the severity of peripheral artery disease in diabetic patientsSilvia Bleda, Joaquin De Haro, Cesar Varela, et al.
Annals of Vascular Surgery|July 18, 2016
Effect of Simvastatin Treatment on "In Vitro" NLRP1 Inflammasome Expression in Peripheral Arterial DiseaseSilvia Bleda, Joaquin de Haro, Ignacio Lopez de Maturana, et al.
Interactive Cardiovascular and Thoracic Surgery|April 21, 2009
Nitric oxide: link between endothelial dysfunction and inflammation in patients with peripheral arterial disease of the lower limbsJoaquin de Haro Miralles, Esther Martínez-Aguilar, Aurora Florez, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Clinical Medicine Insights. Cardiology|November 15, 2016
Rationale and Design of Randomized Clinical Trial for the Assessment of Macitentan Efficiency as Coadjuvant Treatment to Open and Endovascular Revascularization in Critical Limb IschemiaIgnacio Michel, Joaquin De Haro, Silvia Bleda, et al.
Vascular and Endovascular Surgery|August 3, 2010
The role of foot collateral vessels on ulcer healing and limb salvage after successful endovascular and surgical distal procedures according to an angiosome modelCésar Varela, Francisco Acín, Joaquín de Haro, et al.
Journal of Vascular Surgery|January 30, 2014
Circulating anti-β2-glycoprotein I antibodies of peripheral arterial disease patients trigger a genomic overexpression of Toll-like receptor 4 in endothelial cellsCesar Varela, Joaquin de Haro, Silvia Bleda, et al.
Annals of Vascular Surgery|April 23, 2019
Aspirin-Dependent Platelet Inflammatory Inhibition in Healthy Subjects Decreases NLRP-1 InflammasomeJoaquin De Haro, Silvia Bleda, Ilsem Veronica Laime, et al.
Therapeutic Advances in Cardiovascular Disease|March 13, 2018
Differential mRNA expression of inflammasome genes NLRP1 and NLRP3 in abdominal aneurysmal and occlusive aortic diseaseCarmen Gonzalez-Hidalgo, Joaquin De Haro, Silvia Bleda, et al.
Interactive Cardiovascular and Thoracic Surgery|August 20, 2011
Anti-endothelial cell antibodies are associated with peripheral arterial disease and markers of endothelial dysfunction and inflammationCesar Varela, Joaquin de Haro, Silvia Bleda, et al.
Annals of Vascular Surgery|February 14, 2013
Inflammatory burden predicts long-term outcomes in endovascular therapy in peripheral arterial diseaseSilvia Bleda, Joaquin De Haro, Francisco Acin, et al.
Growth Factors (Chur, Switzerland)|July 6, 2012
Impact of VEGF polymorphisms on the severity of peripheral artery disease in diabetic patientsSilvia Bleda, Joaquin De Haro, Cesar Varela, et al.
Annals of Vascular Surgery|July 18, 2016
Effect of Simvastatin Treatment on "In Vitro" NLRP1 Inflammasome Expression in Peripheral Arterial DiseaseSilvia Bleda, Joaquin de Haro, Ignacio Lopez de Maturana, et al.
Interactive Cardiovascular and Thoracic Surgery|April 21, 2009
Nitric oxide: link between endothelial dysfunction and inflammation in patients with peripheral arterial disease of the lower limbsJoaquin de Haro Miralles, Esther Martínez-Aguilar, Aurora Florez, et al.
Pageof 5